Related references
Note: Only part of the references are listed.Discovery of novel selective Janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo[3,4-d]pyrimidin-4-amino scaffold
Yuan Yin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Deprotection of N-Boc Groups under Continuous-Flow High-Temperature Conditions
Bryan Li et al.
JOURNAL OF ORGANIC CHEMISTRY (2019)
Structure-Guided Development of Covalent and Mutant-Selective Pyrazolopyrimidines to Target T790M Drug Resistance in Epidermal Growth Factor Receptor
Julian Engel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Ibrutinib in CLL: a focus on adverse events, resistance, and novel approaches beyond ibrutinib
Varinder Kaur et al.
ANNALS OF HEMATOLOGY (2017)
Design, synthesis, and evaluation of hinge-binder tethered 1,2,3-triazolylsalicylamide derivatives as Aurora kinase inhibitors
Yunkyung Jeong et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Stable isotope-labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults
Ronald de Vries et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Patent Review of Manufacturing Routes to Recently Approved Oncology Drugs: Ibrutinib, Cobimetinib, and Alectinib
David L. Hughes
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2016)
Discovery of (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2-(dimethylamino)ethanone (CHMFL-FLT3-122) as a Potent and Orally Available FLT3 Kinase Inhibitor for FLT3-ITD Positive Acute Myeloid Leukemia
Xixiang Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Direct and two-step bioorthogonal probes for Bruton's tyrosine kinase based on ibrutinib: a comparative study
Nora Liu et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Ibrutinib and novel BTK inhibitors in clinical development
Akintunde Akinleye et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)
Jan A. Burger et al.
LEUKEMIA & LYMPHOMA (2013)
The Triple Role of Fluoride Ions in Palladium-Catalyzed Suzuki-Miyaura Reactions: Unprecedented Transmetalation from [ArPdFL2] Complexes
Christian Amatore et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Covalent Inhibitors of Interleukin-2 Inducible T Cell Kinase (Itk) with Nanomolar Potency in a Whole-Blood Assay
Christoph W. Zapf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Boiling water-catalyzed neutral and selective N-Boc deprotection
Jia Wang et al.
CHEMICAL COMMUNICATIONS (2009)
Orthogonal Cu- and Pd-Based Catalyst Systems for the O- and N-Arylation of Aminophenols
Debabrata Maiti et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Methodology for the synthesis of 1,2-disubstituted arylnaphthalenes from α-tetralones
SS Moleele et al.
TETRAHEDRON (2006)
Lithium perchlorate-catalyzed Boc protection of amines and amine derivatives
A Heydari et al.
ADVANCED SYNTHESIS & CATALYSIS (2005)
Deprotection of a primary Boc group under basic conditions
NJ Tom et al.
TETRAHEDRON LETTERS (2004)
High-performance liquid chromatographic-tandem mass spectrometric evaluation and determination of stable isotope labeled analogs of rofecoxib in human plasma samples from oral bioavailability studies
CM Chavez-Eng et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
LC-MS-MS experiences with internal standards
J Wieling
CHROMATOGRAPHIA (2002)
Determination of pibutidine metabolites in human plasma by LC-MS/MS
K Kato et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2000)